201
Views
5
CrossRef citations to date
0
Altmetric
Review Article

Simple techniques to study multifaceted diabesity in the fly model

&
Pages 549-560 | Received 02 Dec 2018, Accepted 17 Jun 2019, Published online: 19 Jul 2019

References

  • Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. 2008. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57:1759–1767.
  • Al-Anzi B, Sapin V, Waters C, Zinn K, Wyman RJ, Benzer S. 2009. Obesity-blocking neurons in Drosophila. Neuron. 63:329–341.
  • Albu J, Pi-Sunyer F. 1998. Obesity and diabetes. In: Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; p. 697.
  • Alfa RW, Kim SK. 2016. Using Drosophila to discover mechanisms underlying type 2 diabetes. Dis Model Mech. 9:365–376.
  • Álvarez-Rendón JP, Salceda R, Riesgo-Escovar JR. 2018. Drosophila melanogaster as a model for diabetes type 2 progression. BioMed Res Int. 2018:1.
  • Athenstaedt K, Daum G. 2006. The life cycle of neutral lipids: synthesis, storage and degradation. Cell Mol Life Sci. 63:1355–1369.
  • Bader R, Colomb J, Pankratz B, Schröck A, Stocker RF, Pankratz MJ. 2007. Genetic dissection of neural circuit anatomy underlying feeding behavior in Drosophila: distinct classes of hugin‐expressing neurons. J Comp Neurol. 502:848–856.
  • Baker KD, Thummel CS. 2007. Diabetic larvae and obese flies-emerging studies of metabolism in Drosophila. Cell Metab. 6:257–266.
  • Beller M, Bulankina AV, Hsiao H-H, Urlaub H, Jäckle H, Kühnlein RP. 2010. Perilipin-dependent control of lipid droplet structure and fat storage in Drosophila. Cell Metabol. 12:521–532.
  • Bendiner E. 1987. Of peas, fruit flies, and the birth of a science. Hosp Pract. 22:116–120.
  • Bergmeyer HU. 1974. D-glucose. Methods Enzym Anal. 3:1196–1198.
  • Bharucha KN. 2009. The epicurean fly: using Drosophila melanogaster to study metabolism. Pediatr Res. 65:132.
  • Bier E, Bodmer R. 2004. Drosophila, an emerging model for cardiac disease. Gene. 342:1–11.
  • Bilen J, Bonini NM. 2005. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet. 39:153–171.
  • Birse RT, Bodmer R. 2011. Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Crit Rev Biochem Mol Biol. 46:376–385.
  • Birse RT, Choi J, Reardon K, Rodriguez J, Graham S, Diop S, Ocorr K, Bodmer R, Oldham S. 2010. High-fat-diet-induced obesity and heart dysfunction are regulated by the tor pathway in drosophila. Cell Metab. 12:533–544.
  • Blom WA, Lluch A, Stafleu A, Vinoy S, Holst JJ, Schaafsma G, Hendriks HF. 2006. Effect of a high-protein breakfast on the postprandial ghrelin response.Am J Clin Nutr. 83:211–220.
  • Bogart K, Andrews J. 2006. Extraction of total RNA from Drosophila. CGB Tech Report. 10:1–4.
  • Botstein D, Chervitz SA, Cherry M. 1997. Yeast as a model organism. Science. 277:1259–1260.
  • Brasaemle DL. 2007. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 48:2547–2559.
  • Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E. 2001. An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol. 11:213–221.
  • Buescher JL, Musselman LP, Wilson CA, Lang T, Keleher M, Baranski TJ, Duncan JG. 2013. Evidence for transgenerational metabolic programming in Drosophila. Dis Models Mech. 6:1123–1132.
  • Buettner R, Schölmerich J, Bollheimer LC. 2007. High‐fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity. 15:798–808.
  • Burggren WW, Warburton S. 2007. Amphibians as animal models for laboratory research in physiology. ILAR J. 48:260–269.
  • Buse JB. 1999. Overview of current therapeutic options in type 2 diabetes. Diabetes Care. 22:C65–C70.
  • Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD. 2004. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 27:2628–2635.
  • Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L, Group L-S. 2009. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (lead-6). Lancet. 374:39–47.
  • Campos-Ortega JA, Hartenstein V. 1993. Atlas of Drosophila development. Plainview, NY: Cold Spring Harbor Laboratory Press.
  • Canavoso LE, Jouni ZE, Karnas KJ, Pennington JE, Wells MA. 2001. Fat metabolism in insects. Annu Rev Nutr. 21:23–46.
  • Chakrabarti R, Rajagopalan R. 2002. Diabetes and insulin resistance associated disorders: disease and the therapy. Curr Sci. 83:1533–1538.
  • Chan L, Fujimiya M, Kojima H. 2003. In vivo gene therapy for diabetes mellitus. Trends Mol Med. 9:430–435.
  • Chen Q, Ma E, Behar KL, Xu T, Haddad GG. 2002. Role of trehalose phosphate synthase in anoxia tolerance and development in Drosophila melanogaster. J Biol Chem. 277:3274–3279.
  • Chianese R, Chioccarelli T, Cacciola G, Ciaramella V, Fasano S, Pierantoni R, Meccariello R, Cobellis G. 2011. The contribution of lower vertebrate animal models in human reproduction research. Gen Comp Endocrinol. 171:17–27.
  • Chien KR, Moretti A, Laugwitz K-L. 2004. Development ES cells to the rescue. Science. 306:239–240.
  • Chien S, Reiter LT, Bier E, Gribskov M. 2002. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 30:149–151.
  • da Silva VR, Mackey AD, Davis SR, Gregory JF 3rd. 2014. Vitamin B6. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. 11th ed. Philadephia (PA): Lippincott Williams & Wilkins; p. 341–350.
  • Després J-P. 1991. Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipidol. 2:5–15.
  • Dionne MS, Schneider DS. 2008. Models of infectious diseases in the fruit fly Drosophila melanogaster. Dis Models Mech. 1:43–49.
  • dit El Khoury DT, Obeid O, Azar ST, Hwalla N. 2006. Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metabol. 50:260–269.
  • Dong H, Woo SL. 2001. Hepatic insulin production for type 1 diabetes. Trends Endocrinol Metabol. 12:441–446.
  • Dow JA, Davies SA. 2006. The Malpighian tubule: rapid insights from post-genomic biology. J Insect Physiol. 52:365–378.
  • Felig P, Marliss E, Cahill GF. 1969. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 281:811–816.
  • Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. 2004. Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol. 5:763.
  • Ferre F. 1992. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl. 2:1–9.
  • Fiehn O. 2002. Metabolomics – the link between genotypes and phenotypes, functional genomics. Plant Mol Biol. 48:155–171.
  • Forbes JM, Cooper ME. 2013. Mechanisms of diabetic complications. Physiol Rev. 93:137–188.
  • Froy O. 2010. Metabolism and circadian rhythms-implications for obesity. Endocr Rev. 31:1–24.
  • Gáliková M, Diesner M, Klepsatel P, Hehlert P, Xu Y, Bickmeyer I, Predel R, Kühnlein RP. 2015. Energy homeostasis control in Drosophila adipokinetic hormone mutants. Genetics. 201:665–683.
  • Giugliano D, Ceriello A, Esposito K. 2008. Glucose metabolism and hyperglycemia. Am J Clin Nutr. 87:217S–222S.
  • Golay A, Ybarra J. 2005. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metabol. 19:649–663.
  • Goldstein BJ, Ahmad F, Ding W, Li P-M, Zhang W-R. 1998. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol Cell Biochem. 182:91–99.
  • Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. 2000. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem. 275:4283–4289.
  • Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC. 1975. Glutaric aciduria; a ‘new’ disorder of amino acid metabolism. Biochem Med. 12:12–21.
  • Graham P, Pick L. 2017. Drosophila as a model for diabetes and diseases of insulin resistance. Curr Topic Develop Biol. 121:397–419.
  • Green C, Burnet B, Connolly K. 1983. Organization and patterns of inter-and intraspecific variation in the behaviour of Drosophila larvae. Anim Behav. 31:282–291.
  • Greenspan P, Mayer EP, Fowler SD. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 100:965–973.
  • Griffin JL. 2003. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr Opin Chem Biol. 7:648–654.
  • Grönke S, Beller M, Fellert S, Ramakrishnan H, Jäckle H, Kühnlein RP. 2003. Control of fat storage by a Drosophila pat domain protein. Curr Biol. 13:603–606.
  • Grönke S, Mildner A, Fellert S, Tennagels N, Petry S, Müller G, Jäckle H, Kühnlein RP. 2005. Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metabol. 1:323–330.
  • Grover J, Yadav S, Vats V. 2002. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 81:81–100.
  • Guilgur LG, Prudêncio P, Sobral D, Liszekova D, Rosa A, Martinho RG. 2014. Requirement for highly efficient pre-mRNA splicing during Drosophila early embryonic development. Elife. 3:e02181.
  • Gutierrez E, Wiggins D, Fielding B, Gould AP. 2007. Specialized hepatocyte-like cells regulate Drosophila lipid metabolism. Nature. 445:275.
  • Halton TL, Hu FB. 2004. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr. 23:373–385.
  • Harbison ST, Mackay TF, Anholt RR. 2009. Understanding the neurogenetics of sleep: progress from Drosophila. Trends Genet. 25:262–269.
  • Havula E, Teesalu M, Hyötyläinen T, Seppälä H, Hasygar K, Auvinen P, Orešič M, Sandmann T, Hietakangas V. 2013. Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in drosophila. PLoS Genet. 9:e1003438.
  • Helfand SL, Rogina B. 2003. From genes to aging in Drosophila. Adv Gen. 49:67–109.
  • Herrero M, Remesar X, Bladé C, Arola L. 1997. Muscle amino acid pattern in obese rats. Int J Obes Relat Metab Disord. 21:698.
  • Hildebrandt A, Bickmeyer I, Kühnlein RP. 2011. Reliable Drosophila body fat quantification by a coupled colorimetric assay. PloS One. 6:e23796.
  • Hori Y. 2009. Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus. Med Mol Morphol. 42:195.
  • Horner MA, Pardee K, Liu S, King-Jones K, Lajoie G, Edwards A, Krause HM, Thummel CS. 2009. The Drosophila DHR96 nuclear receptor binds cholesterol and regulates cholesterol homeostasis. Genes Develop. 23:2711–2716.
  • Hotamisligil GS, Spiegelman BM. 1994. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes. 43:1271–1278.
  • Hunziker W, Kiener TK, Xu J. 2009. Vertebrate animal models unravel physiological roles for zonula occludens tight junction adaptor proteins. Ann New York Acad Sci. 1165:28–33.
  • Huynh K, Schneider M, Gareau M. 2016. Altering the gut microbiome for cognitive benefit? Gut-Brain Axis. 319–337. https://doi.org/10.1016/B978-0-12-802304-4.00015-3
  • Hwang RY, Zhong L, Xu Y, Johnson T, Zhang F, Deisseroth K, Tracey WD. 2007. Nociceptive neurons protect Drosophila larvae from parasitoid wasps. Curr Biol. 17:2105–2116.
  • Ikeya T, Galic M, Belawat P, Nairz K, Hafen E. 2002. Nutrient-dependent expression of insulin-like peptides from neuroendocrine cells in the CNS contributes to growth regulation in Drosophila. Curr Biol. 12:1293–1300.
  • Inzucchi SE. 2002. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA. 287:360–372.
  • Jakubowski BR, Longoria RA, Shubeita GT. 2012. A high throughput and sensitive method correlates neuronal disorder genotypes to Drosophila larvae crawling phenotypes. Fly. 6:303–308.
  • Janghorbani M, Van Dam RM, Willett WC, Hu FB. 2007. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 166:495–505.
  • Jeganathan S, Abdullahi A, Zargar S, Maeda N, Riddell MC, Adegoke OA. 2014. Amino acid‐induced impairment of insulin sensitivity in healthy and obese rats is reversible. Physiol Rep. 2:e12067.
  • Jun H-S, Yoon J-W. 2005. Approaches for the cure of type 1 diabetes by cellular and gene therapy. Curr Gene Ther. 5:249–262.
  • Jung M, Park M, Lee HC, Kang Y-H, Kang ES, Kim SK. 2006. Antidiabetic agents from medicinal plants. Curr Med Chem. 13:1203–1218.
  • Kaletta T, Hengartner MO. 2006. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov. 5:387.
  • Kaur G, Dufour JM. 2012. Cell lines: valuable tools or useless artifacts. Spermatogenesis. 2:1–5.
  • Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB, Spiegelman BM. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 101:1–9.
  • Kim S-J, Nian C, Doudet DJ, McIntosh CH. 2008a. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic nod mice partially via t-cell modulation. Diabetes. 57:1331.
  • Kim S-J, Nian C, Doudet DJ, McIntosh CH. 2008b. Inhibition of dipeptidyl peptidase IV (DPP-IV) with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin (STZ)-induced diabetic mice. Diabetes. 57:1331–1339.
  • Kim SK, Rulifson EJ. 2004. Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells. Nature. 431:316.
  • Kim T, Kim Y. 2005. Overview of innate immunity in Drosophila. J Biochem Mol Biol. 38:121.
  • Kim Y-B, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. 1999. Normal insulin-dependent activation of AKT/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest. 104:733–741.
  • Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim Y-B, Sharpe AH, et al. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1b-deficient mice. Mol Cell Biol. 20:5479–5489.
  • Krieger JW, Sitren HS, Daniels MJ, Langkamp-Henken B. 2006. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression. Am J Clin Nutr. 83:260–274.
  • Kühnlein RP. 2011. The contribution of the Drosophila model to lipid droplet research. Prog Lipid Res. 50:348–356.
  • Kunte AS, Matthews KA, Rawson RB. 2006. Fatty acid auxotrophy in Drosophila larvae lacking srebp. Cell Metab. 3:439–448.
  • Lee G, Park JH. 2004. Hemolymph sugar homeostasis and starvation-induced hyperactivity affected by genetic manipulations of the adipokinetic hormone-encoding gene in Drosophila melanogaster. Genetics. 167:311–323.
  • Lee HC, Kim S-J, Kim K-S, Shin H-C, Yoon J-W. 2000. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature. 408:483.
  • Leopold P, Perrimon N. 2007. Drosophila and the genetics of the internal milieu. Nature. 450:186.
  • Lieschke GJ, Currie PD. 2007. Animal models of human disease: Zebrafish swim into view. Nat Rev Genet. 8:353.
  • Linn T, Strate C, Schneider K. 1999. Diet promotes beta-cell loss by apoptosis in prediabetic nonobese diabetic mice. Endocrinology. 140:3767–3773.
  • Liu J, Li T, Yang D, Ma R, Moran T, Smith W. 2012. Synphilin-1 alters metabolic homeostasis in a novel Drosophila obesity model. Int J Obes. 36:1529.
  • Liu Z, Wang X, Yu Y, Li X, Wang T, Jiang H, Ren Q, Jiao Y, Sawa A, Moran T, et al. 2008. A Drosophila model for LRRK2-linked parkinsonism. Proc Nat Acad Sci. 105:2693–2698.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative pcr and the 2− δδct method. Methods. 25:402–408.
  • Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA. 2009. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA. 106:15768–15773.
  • Marder E, Calabrese RL. 1996. Principles of rhythmic motor pattern generation. Physiol Rev. 76:687–717.
  • Marliss EB, Gougeon R. 2002. Diabetes mellitus, lipidus et… proteinus! Diabetes Care. 25:1474–1476.
  • Matzkin LM, Johnson S, Paight C, Markow TA. 2013. Preadult parental diet affects offspring development and metabolism in Drosophila melanogaster. PLoS One. 8:e59530.
  • McGuire SE, Deshazer M, Davis RL. 2005. Thirty years of olfactory learning and memory research in Drosophila melanogaster. Prog Neurobiol. 76:328–347.
  • Meier JJ, Bhushan A, Butler PC. 2006. The potential for stem cell therapy in diabetes. Pediatr Res. 59:65R.
  • Melcher C, Bader R, Pankratz MJ. 2007. Amino acids, taste circuits, and feeding behavior in Drosophila: towards understanding the psychology of feeding in flies and man. J Endocrinol. 192:467–472.
  • Mishra M, Barik BK. 2018. Behavioral teratogenesis in Drosophila melanogaster. Methods Mol Biol. 1797:277–298.
  • Mo R, Jiang T, Di J, Tai W, Gu Z. 2014. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery. Chem Soc Rev. 43:3595–3629.
  • Moghadam NN, Holmstrup M, Manenti T, Mouridsen MB, Pertoldi C, Loeschcke V. 2015. The role of storage lipids in the relation between fecundity, locomotor activity, and lifespan of Drosophila melanogaster longevity-selected and control lines. PLoS One. 10:e0130334.
  • Mohan V, Shah S, Saboo B. 2013. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the a1chieve study. J Assoc Phys India. 61:12–15.
  • Morral N. 2003. Novel targets and therapeutic strategies for type 2 diabetes. Trends Endocrinol Metabol. 14:169–175.
  • Morrison TB, Weis JJ, Wittwer CT. 1998. Quantification of low-copy transcripts by continuous SYBR green I monitoring during amplification. Biotechniques. 24:954–958, 960, 962.
  • Musselman LP, Fink JL, Narzinski K, Ramachandran PV, Hathiramani SS, Cagan RL, Baranski TJ. 2011. A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila. Dis Models Mech. 4:842–849.
  • Na J, Musselman LP, Pendse J, Baranski TJ, Bodmer R, Ocorr K, Cagan R. 2013. A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet. 9:e1003175.
  • Nichols CD, Becnel J, Pandey UB. 2012. Methods to assay Drosophila behavior. J Visual Exper. 7:pii: 3795.
  • O’doherty RM, Lehman DL, Télémaque-Potts S, Newgard CB. 1999. Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes. 48:2022–2027.
  • Oldham S, Hafen E. 2003. Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13:79–85.
  • Padmanabha D, Baker KD. 2014. Drosophila gains traction as a repurposed tool to investigate metabolism. Trends Endocrinol Metabol. 25:518–527.
  • Palm W, Sampaio JL, Brankatschk M, Carvalho M, Mahmoud A, Shevchenko A, Eaton S. 2012. Lipoproteins in Drosophila melanogaster – assembly, function, and influence on tissue lipid composition. PLoS Genet. 8:e1002828.
  • Pandey UB, Nichols CD. 2011. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev. 63:411. pr. 110.003293.
  • Pappus SA, Mishra M. 2018. A Drosophila model to decipher the toxicity of nanoparticles taken through oral routes. Adv Exp Med Biol. 1048:311–322.
  • Pasco MY, Léopold P. 2012. High sugar-induced insulin resistance in Drosophila relies on the lipocalin neural lazarillo. PLoS One. 7:e36583.
  • Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. 2002. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 25:608–613.
  • Patel D, Prasad S, Kumar R, Hemalatha S. 2012. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2:320.
  • Patel R. 2014. Metabolic disorders: an overview and key messages for pharmacists. Eur J Hosp Pharm. 21:355–360.
  • Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res. 29:45e–e45.
  • Pfaffl MW, Hageleit M. 2001. Validities of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR. Biotechnol. Lett. 23:275–282.
  • Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (rest©) for group-wise comparison and statistical analysis of relative expression results in real-time pcr. Nucleic Acids Res. 30:36e–e36.
  • Piccolo L, Bonaccorso R, Onorati M. 2015. Nuclear and cytoplasmic soluble proteins extraction from a small quantity of Drosophila’s whole larvae and tissues. Int J Mol Sci. 16:12360–12367.
  • Pitsouli C, Perrimon N. 2008. Developmental biology: our fly cousins’ gut. Nature. 454:592.
  • Prasad S, Kulshreshtha A, Qureshi TN. 2009. Antidiabetic activity of some herbal plants in streptozotocin induced diabetic albino rats. Pak J Nutr. 8:551–557.
  • Prudêncio P, Guilgur LG. 2015. Protein extraction from Drosophila embryos and ovaries. Bio-protocol. 5:e1459.
  • Reaven GM. 1995. Pathophysiology of insulin resistance in human disease. Physiol Rev. 75:473–486.
  • Reed LK, Williams S, Springston M, Brown J, Freeman K, DesRoches CE, Sokolowski MB, Gibson G. 2010. Genotype-by-diet interactions drive metabolic phenotype variation in Drosophila melanogaster. Genetics. 185:1009.
  • Reis T, Van Gilst MR, Hariharan IK. 2010. A buoyancy-based screen of Drosophila larvae for fat-storage mutants reveals a role for Sir2 in coupling fat storage to nutrient availability. PLoS Genet. 6:e1001206.
  • Richards C. 2014. Research paper based on pathology lectures [thesis]. At medlink and vet-medlink 2014.
  • Riddle M. 1996. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine. Horm Metab Res. 28:430–433.
  • Rondinone CM, Wang L-M, Lonnroth P, Wesslau C, Pierce JH, Smith U. 1997. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Nat Acad Sci. 94:4171–4175.
  • Rosini TC, Silva Asrd, Moraes CD. 2012. Diet-induced obesity: Rodent model for the study of obesity-related disorders. Revista da Associacao Medica Brasileira. 58:383–387.
  • Rulifson EJ, Kim SK, Nusse R. 2002. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science. 296:1118–1120.
  • Rusten TE, Lindmo K, Juhász G, Sass M, Seglen PO, Brech A, Stenmark H. 2004. Programmed autophagy in the drosophila fat body is induced by ecdysone through regulation of the PI3K pathway. Develop Cell. 7:179–192.
  • Saghatelian A, Cravatt BF. 2005. Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol. 9:62–68.
  • Saxena A, Vikram NK. 2004. Role of selected Indian plants in management of type 2 diabetes: a review. J Alt Comp Med. 10:369–378.
  • Schlegel A, Stainier DY. 2007. Lessons from ‘lower’ organisms: what worms, flies, and zebrafish can teach us about human energy metabolism. PLoS Genet. 3:e199.
  • Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. 2000. Quantitative reverse transcription–polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem. 285:194–204.
  • Schneider K, Laube H, Linn T. 1996. A diet enriched in protein accelerates diabetes manifestation in nod mice. Acta Diabetol. 33:236–240.
  • Scott RC, Schuldiner O, Neufeld TP. 2004. Role and regulation of starvation-induced autophagy in the drosophila fat body. Dev Cell. 7:167–178.
  • Ségalat L. 2007. Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol. 2:231–236.
  • Shepherd PR, Kahn BB. 1999. Glucose transporters and insulin action – implications for insulin resistance and diabetes mellitus. N Engl J Med. 341:248–257.
  • Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Nat Acad Sci. 96:13656–13661.
  • Song W, Cheng D, Hong S, Sappe B, Hu Y, Wei N, Zhu C, O’Connor MB, Pissios P, Perrimon N. 2017. Midgut-derived activin regulates glucagon-like action in the fat body and glycemic control. Cell Metabol. 25:386–399.
  • Song W, Ren D, Li W, Jiang L, Cho KW, Huang P, Fan C, Song Y, Liu Y, Rui L. 2010. SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab. 11:427–437.
  • Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 321:405–412.
  • Teleman AA. 2010. Molecular mechanisms of metabolic regulation by insulin in drosophila. Biochem J. 425:13–26.
  • Thompson SN. 2003. Trehalose – the insect ‘blood’ sugar. Adv Insect Physiol. 31:85.
  • Tweeddale H, Notley-McRobb L, Ferenci T. 1998. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (‘metabolome’) analysis. J Bacteriol. 180:5109–5116.
  • Van Veldhoven PP, Swinnen JV, Esquenet M, Verhoeven G. 1997. Lipase‐based quantitation of triacylglycerols in cellular lipid extracts: requirement for presence of detergent and prior separation by thin‐layer chromatography. Lipids. 32:1297–1300.
  • Verma IM, Naldini L, Kafri T, Miyoshi H, Takahashi M, Blömer U, Somia N, Wang L, Gage F. 2000. Gene therapy: promises, problems and prospects. In: Boulyjenkov V, Berg K, Christen Y, (eds). Genes and Resistance to Disease. Berlin, Heidelberg: Springer; p. 147–157.
  • Voltarelli JC, Couri CEB, Stracieri ABPL, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KCR, Foss-Freitas MC, Simões BP, et al. 2007. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 297:1568–1576.
  • Wang JW, Sylwester AW, Reed D, Wu D-AJ, Soll DR, Wu C-F. 1997. Morphometric description of the wandering behavior in drosophila larvae: aberrant locomotion in na + and k + channel mutants revealed by computer-assisted motion analysis. J Neurogenetics. 11:231–254.
  • West KM, Kalbfleisch JM. 1966. Glucose tolerance, nutrition, and diabetes in Uruguay, Venezuela, Malaya, and East Pakistan. Diabetes. 15:9–18.
  • Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metabol. 86:1930–1935.
  • Winer J, Jung CKS, Shackel I, Williams PM. 1999. Development and validation of real-time quantitative reverse transcriptase–polymerase chain reaction for monitoring gene expression in cardiac myocytesin vitro. Anal Biochem. 270:41–49.
  • Wyatt G, Kalf G. 1957. The chemistry of insect hemolymph: II. Trehalose and other carbohydrates. J Gen Physiol. 40:833–847.
  • Yoon J-W, Jun H-S. 2002. Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol Med. 8:62–68.
  • Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S. 2003. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Nat Acad Sci. 100:7253–7258.
  • Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R. 2005. Lipolysis: pathway under construction. Curr Opin Lipidol. 16:333–340.
  • Zhang Y, Xi Y. 2015. Fat body development and its function in energy storage and nutrient sensing in drosophila melanogaster. J Tissue Sci Eng. 6:1.
  • Zhao X, Karpac J. 2017. Muscle directs diurnal energy homeostasis through a myokine-dependent hormone module in drosophila. Curr Biol. 27:1941–1955. e1946.
  • Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A. 2004. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 306:1383–1386.
  • Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. 2014. Diabetes: a 21st century challenge. Lancet Diab Endocrinol. 2:56–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.